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Abstract 
Background: The triglyceride glucose (TyG) index has been considered a simple surrogate marker of insulin resist-
ance. However, few studies have investigated the relationship between the TyG index and coronary artery calcification 
(CAC). Thus, we investigated the relationship between the TyG index and CAC in healthy Korean adults.
Methods: In total, 4319 participants who underwent cardiac computed tomography (CT) in a health promotion 
center were enrolled. Anthropometric profiles and multiple cardiovascular risk factors were measured. The TyG index 
was calculated as ln [fasting triglycerides (mg/dL) × fasting glucose (mg/dL)/2], and the insulin resistance index of 
homeostasis model assessment (HOMA-IR) was estimated. The CAC was measured using multidetector CT, and CAC 
presence was defined as an Agatston score of >0.
Results: All subjects were stratified into four groups based on their TyG indices. Significant differences were observed 
in cardiovascular parameters among the groups, and the prevalence of CAC significantly increased with increasing 
TyG index. In the logistic regression analysis after adjustment for multiple risk factors, the odds ratio for the preva-
lence of CAC, when comparing the highest and lowest quartiles of the TyG index was 1.95 (95% CI 1.23–3.11; P for 
trend = 0.01); the odds ratio for the prevalence of CAC, when comparing the highest and lowest quartiles of HOMA-IR 
was 1.64 (95% CI 1.12–2.40; P for trend = 0.04). In the receiver operating characteristics analysis, the TyG index was 
superior to HOMA-IR in predicting CAC.
Conclusion: The TyG index is more independently associated with the presence of coronary artery atherosclerosis 
than is HOMA-IR in healthy Korean adults.
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Background
Cardiovascular disease (CVD) is the leading cause of 
morbidity and mortality worldwide. Coronary artery 
calcification (CAC), as determined by multidetector 
computed tomography (CT), is a sensitive measure for 
detecting the existence of early coronary artery athero-
sclerosis. Moreover, CAC can have prognostic value for 
predicting future CVD events [1–3].
Insulin resistance (IR) is associated with an increased 
risk of hyperglycemia, hypertension, and dyslipidemia, 
which increases the risk of inflammation, altered coagu-
lation, and atherosclerosis. Many studies have demon-
strated that IR is one of the most important contributing 
factors to CVD [4–6].
Recently, the triglyceride glucose (TyG) index has been 
proposed as a reliable and simple surrogate marker of 
IR. This index is correlated with IR, as assessed by the 
hyperinsulinemic euglycemic clamp test and the homeo-
static model assessment of insulin resistance (HOMA-IR) 
[7–11].
Few studies have examined the relationship between 
the TyG index and CVD events, and their results have 
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been inconsistent [12, 13]. In addition, no study has 
investigated the relationship between the TyG index and 
CAC in healthy adults.
Therefore, in the present study, we investigated the 
relationship between the TyG index and CAC and com-
pared the index with HOMA-IR in healthy Korean adults.
Methods
Study population
The study population comprised 5217 Korean subjects 
who participated in a comprehensive health examination, 
including cardiac CT, as part of a self-referred health 
checkup program at the Gangnam Severance Hospital 
Health Promotion Center from January 2008 to February 
2015 [14]. The exclusion criteria of this study included 
patients with elevated triglyceride levels (≥400  mg/dL), 
any malignancy, acute inflammatory disease, or infec-
tious disease. We also excluded subjects with a history 
of angina, myocardial infarction or cerebrovascular 
accidents, hypertension, diabetes, or renal disease. Sub-
jects taking statins or triglyceride-lowering medications 
(fenofibrate or omega-3) were also excluded. Ultimately, 
4319 subjects were enrolled in our final analysis. The 
study protocol was approved by the Institutional Review 
Board of Yonsei University College of Medicine.
Clinical characteristics
Height and weight were measured, and body mass index 
(BMI) was calculated by dividing the weight (kg) by the 
square of the height  (m2). Lifestyle, personal medical his-
tory of acute or chronic illness, and medication history 
were assessed using a standard questionnaire. Systolic 
and diastolic blood pressures were measured by experi-
enced technicians using an automated blood pressure 
(BP) monitor (HEM-7080IC; Omron Healthcare, Lake 
Forest, IL, USA) by placing the arm at heart level after a 
5-min rest period. An individual who drinks at least 20 g/
day of alcohol was defined as an alcohol drinker. Regu-
lar exercise was reported to be positive if the participant 
performed moderate exercise for more than 30  min at 
least three times a week. Current smokers were defined 
as those who reported having smoked cigarettes regularly 
over the previous 6 months.
Biochemical parameters
Blood samples were obtained from all participants after 
12  h of fasting. Fasting plasma glucose (FPG), total 
cholesterol (TC), high-density lipoprotein cholesterol 
(HDL-C), and triglyceride (TG) levels were determined 
by enzymatic methods using a Hitachi 7600-120 auto-
mated chemistry analyzer (Hitachi, Tokyo, Japan). The 
low-density lipoprotein cholesterol (LDL-C) level was 
calculated according to the Friedewald formula. The 
TyG index was calculated as ln[fasting triglycerides (mg/
dL) × fasting glucose (mg/dL)/2] [7]. The fasting serum 
insulin level was determined using chemiluminescence 
(RIA kit, Daiichi, Japan), and the HOMA-IR index 
was calculated using the following formula: HOMA-
IR  =  fasting insulin (µU/mL)  ×  fasting glucose (mg/
dL)/405.
CAC measurements by multidetector CT
Coronary artery calcification was determined using a 
multidetector CT scanner (Philips Brilliance 64; Philips 
Medical System, Best, The Netherlands). A standard 
prospective ECG-gating protocol with a step-and-shoot 
technique was used, as previously described [15]. Coro-
nary CT images were analyzed by one of three expe-
rienced radiologists, all of whom were blinded to the 
laboratory and clinical details of the participants at the 
time of analysis. The quantitative coronary artery calcifi-
cation score (CACS) was calculated using dedicated soft-
ware and was expressed as an Agatston score [15]. The 
presence of CAC was defined as an Agatston score of >0.
Statistical analysis
Continuous variables with a normal distribution were 
expressed as the mean ±  SD, whereas continuous vari-
ables with a skewed distribution were presented as 
median (interquartile range) and were log transformed 
for analysis. Intergroup comparisons were performed 
using ANOVA tests. Categorical variables with percent-
ages were compared using Chi square tests. The relation-
ships between CAC and various clinical parameters were 
examined using Pearson’s correlation. The relationship 
between the TyG index, HOMA-IR and the presence 
of CAC was analyzed using logistic regression analysis 
while controlling for potential confounders. Covariates in 
the multivariate model, which were chosen for their clini-
cal importance, as well as statistical significance, were 
age, sex, SBP, BMI, LDL-C, HDL-C, smoking status, alco-
hol intake, and exercise habits. The area under the curve 
(AUC) of the receiver operating characteristics (ROC) 
curve and a 95% confidence interval (CI) were calcu-
lated to compare the predictive power of the TyG index 
and HOMA-IR for CAC. Subgroup analysis was per-
formed after categorizing the subjects according to age, 
sex, BMI, BP, and LDL-C, and the odds ratio (OR) was 
compared between the highest and lowest quartiles of 
the TyG indices. All statistical analyses were performed 
using the SPSS statistical package, version 20.0 (SPSS, 
Inc., Chicago, IL, USA) and MedCalc (MedCalc software, 
Olstead, Belgium). P values of <0.05 were considered sta-
tistically significant.
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Results
Table  1 shows the clinical and biochemical character-
istics of the enrolled subjects. The subjects were strati-
fied into four groups based on their TyG index levels. 
Significant differences in metabolic parameters were 
observed among the groups. Age, SBP, DBP, BMI, FPG 
levels, TC levels, TG levels, LDL-C levels, insulin levels, 
and HOMA-IR increased and HDL-C levels decreased 
with an increase in the TyG index. In addition, significant 
differences in smoking status and alcohol intake were 
observed among the groups. Exercise habits were not 
found to be significant according to the TyG index.
In total, 4319 subjects were included. Of these, 3474 
did not exhibit coronary artery calcification (CACS = 0), 
and the remaining 845 exhibited some evidence of CAC 
(CACS > 0, 19.6%). The prevalence of CAC and the mean 
CACS significantly increased with an increase in the TyG 
index (Table 2; Fig. 1).
Pearson correlation analysis was performed to exam-
ine the relationship between log-transformed CACS and 
various clinical parameters (Table  3). CAC showed sig-
nificant correlations with the TyG index and HOMA-IR, 
and the correlation between the TyG index and CAC was 
better than the correlation between HOMA-IR and CAC.
The relationship between the TyG index and the pres-
ence of CAC (CACS  >  0) was explored by categorizing 
the TyG index into quartiles using the first quartile as 
the reference (Table 4). An unadjusted multivariate logis-
tic regression analysis, with I set as a reference, revealed 
that the TyG indices for II, III and IV had increased OR 
Table 1 Clinical characteristics of subjects based on the TyG index
Data are represented as the mean ± SD, number (percentage), or median (interquartile range)
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low-density 
lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, HOMA-IR homeostasis model assessment of insulin resistance
Quartiles of the TyG index P
I (lowest) II III IV (highest)
N 1080 1083 1078 1078
Age (years) 50.39 ± 9.86 52.77 ± 8.95 54.08 ± 8.87 56.36 ± 9.35 <0.01
Sex (M/F) 486/594 555/528 632/446 651/427
SBP (mmHg) 118.35 ± 12.34 121.39 ± 12.16 125.49 ± 11.02 126.89 ± 11.28 <0.01
DBP (mmHg) 73.15 ± 7.15 75.17 ± 7.26 76.90 ± 8.13 78.43 ± 8.74 <0.01
BMI (kg/m2) 22.16 ± 2.81 23.26 ± 3.11 23.96 ± 2.88 24.97 ± 2.85 <0.01
FPG (mg/dL) 86.42 ± 9.23 92.79 ± 9.39 96.37 ± 9.74 98.87 ± 9.89 <0.01
TC (mg/dL) 184.55 ± 33.41 193.79 ± 33.68 195.99 ± 35.07 205.77 ± 35.03 <0.01
TG (mg/dL) 55 (48–62) 80 (73–89) 112 (100–124) 185 (156–230) <0.01
LDL-C (mg/dL) 110.45 ± 29.65 121.94 ± 30.11 124.59 ± 31.50 125.76 ± 31.49 <0.01
HDL-C (mg/dL) 58.59 ± 12.88 53.05 ± 12.13 47.56 ± 10.72 42.77 ± 8.74 <0.01
TyG index 7.75 ± 0.21 8.22 ± 0.11 8.59 ± 0.11 9.15 ± 0.27 <0.01
Insulin (µU/mL) 2.95 (2.13–4.5) 4.0 (2.8–5.8) 4.6 (3.4–6.5) 5.5 (3.8–7.6) <0.01
HOMA-IR 0.64 (0.44–0.99) 0.90 (0.64–1.33) 1.09 (0.78–1.57) 1.34 (0.88–1.87) <0.01
Alcohol consumption (%) 92 (8.5) 95 (8.8) 120 (11.1) 201 (18.6) 0.03
Regular exercise (%) 129 (11.9) 148 (13.7) 128 (11.9) 101 (9.4) 0.12
Smoking (%) 329 (30.5) 354 (32.7) 367 (34.0) 393 (36.5) <0.01
Table 2 Prevalence of subjects with CAC and means of ln(CACS + 1) based on the TyG index
Data are represented as the mean ± SE or as a number (percentage)
TyG triglyceride glucose index, CAC coronary artery calcification, CACS coronary artery calcification score
Quartiles of TyG index P
I (lowest) II III IV (highest)
N 1080 1083 1078 1078
ln(CACS + 1) 0.49 ± 0.04 0.82 ± 0.05 0.95 ± 0.06 1.14 ± 0.06 <0.01
CACS > 0, N (%) 133 (12.3) 214 (19.8) 230 (21.3) 268 (24.9) <0.01
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for the presence of CAC in all subjects (Model 1). After 
adjusting for confounding variables, including age, sex, 
SBP, BMI, LDL-C levels, HDL-C levels, smoking status, 
alcohol, and exercise habit, these relationships remained 
significant (P for trend < 0.05) (Model 3).
We further evaluated the relationship between the 
HOMA-IR and the presence of CAC by categoriz-
ing HOMA-IR into quartiles using the first quartile as 
the reference (Table  4). The higher HOMA-IR quartile 
was significantly associated with the presence of CAC, 
and these relationships remained significant even after 
adjusting for confounding variables. After adjustment for 
multiple risk factors, the OR (95% CI) for having CAC of 
HOMA-IR in the highest quartile was 1.64 (1.12–2.40), 
whereas the OR of the TyG index in the highest quar-
tile was 1.95 (1.23–3.11). The AUC (95% CI) of the ROC 
curve for the TyG index at 0.629 (0.598–0.660) was sig-
nificantly higher than that of the HOMA-IR at 0.585 
(0.554–0.616) (P = 0.016). These results suggest that the 
TyG index is better than HOMA-IR in predicting CAC.
Adjusted ORs of CAC subgroups were significant 
regardless of age, sex, BMI, BP, or LDL-C levels. In 
addition, subjects who were ≥50  years old, male, obese 
(BMI ≥  25  kg/m2), had high BP (≥120/80  mmHg), and 
had high LDL-C (≥130 mg/dL) showed higher ORs com-
pared with those without these risk factors (Additional 
file 1: Table S1).
Discussion
In this study, we investigated the relationship between 
the TyG index and CAC in healthy Korean adults and 
found that the prevalence of CAC was significantly asso-
ciated with the TyG index, and was independent of con-
ventional cardiovascular risk factors. To the best of our 
knowledge, this is the first study to investigate the rela-
tionship between the TyG index and the presence of early 
coronary artery atherosclerosis in healthy adults. Fur-
thermore, the TyG index showed higher predictability for 
CAC than did HOMA-IR.
IR has been proposed as an important cause of sev-
eral metabolic disease [16–18] and CVD [4–6]. The gold 
standard technique for assessing insulin sensitivity is the 
hyperinsulinemic euglycemic clamp test [19], but this 
method is invasive, laborious, and expensive, and it can 
only be used for research purposes. Therefore, HOMA-
IR was developed as a more convenient method for meas-
uring IR and is widely used in clinical settings [20, 21]. 
Recently, some studies have shown that the TyG index is 
correlated with IR, as assessed using the hyperinsuline-
mic euglycemic clamp test and HOMA-IR, and the TyG 
index has been considered to be a surrogate marker of IR 
[7–9, 22, 23]. In addition, some studies have shown that 
the predictive value of the TyG index is better than that 
of HOMA-IR [10, 24].
Few reports on the relationship between the TyG index 
and CVD events exist, and these are controversial. In a 
recent study, Sanchez-Inigo et al. reported that the TyG 
index might be useful to identify individuals at high risk 
of a CVD event [13], whereas another study has shown 
that the TyG index does not predict CVD events [12]. 
Furthermore, to date, only two studies have examined 
10
20
30
I II III IV
Fig. 1 Prevalence of subjects with CAC based on the TyG index
Table 3 Correlations between CAC [ln(CACS + 1)] and risk 
factors
Continuous variables with skewed distributions (TG, insulin, HOMA-IR) were log 
transformed for analysis
SBP systolic blood pressure, DBP diastolic blood pressure, BMI body mass index, 
FPG fasting plasma glucose, TC total cholesterol, TG triglyceride, LDL-C low-
density lipoprotein cholesterol, HDL-C high-density lipoprotein cholesterol, TyG 
triglyceride glucose index, HOMA-IR homeostasis model assessment of insulin 
resistance
R P
Age 0.357 <0.01
Sex (male) 0.299 <0.01
SBP 0.161 <0.01
DBP 0.160 <0.01
BMI 0.116 <0.01
FPG 0.145 <0.01
TC 0.017 0.30
TG 0.109 <0.01
LDL-C 0.032 0.06
HDL-C −0.105 <0.01
TyG index 0.138 <0.01
Insulin 0.098 <0.01
HOMA-IR 0.119 <0.01
Alcohol consumption 0.011 0.51
Regular exercise 0.026 0.21
Smoking 0.039 0.04
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the relationship between the TyG index and subclinical 
atherosclerosis. Irace et  al. reported that the TyG index 
is significantly associated with carotid artery atheroscle-
rosis after adjustment for traditional cardiovascular risk 
factors [25]. Recently, Lee et al. showed an independent 
relationship between the TyG index and significant coro-
nary artery stenosis in patients with type 2 diabetes [26], 
but the sample size was small (n = 888) and only subjects 
with type 2 diabetes were included.
In the present study, we demonstrated that the TyG 
index was independently associated with the presence of 
CAC in healthy adults. Compared with HOMA-IR, the 
TyG index is better for predicting subclinical atheroscle-
rosis, and this result corroborates the previous finding 
that the TyG index showed a stronger association with 
carotid atherosclerosis than did HOMA-IR [25].
Although the mechanism underlying the relationship 
between the TyG index and CAC has not been clarified, 
it may be linked to IR. Many studies have indicated that 
IR leads to inflammation, altered coagulation and ath-
erosclerosis [27–30]. Furthermore, an independent asso-
ciation between IR and CAC has been reported [31–33]. 
Both the TyG index and HOMA-IR are well known rep-
resentative markers of IR, and they are closely related to 
each other. However, our findings showed that the TyG 
index was better associated with the presence of coro-
nary artery atherosclerosis than was HOMA-IR, and this 
result may be explained by the fact that the two indices 
reflect different aspects of IR. The TyG index reflects IR 
mainly in the muscle [34–36], and HOMA-IR reflects IR 
mainly in the liver [37, 38], which may have caused the 
difference. Peripheral insulin resistance may be a useful 
marker of coronary artery atherosclerosis [25].
Our study also had some limitations. First, this was 
a cross-sectional observational study that could not 
definitively establish causality. Thus, the precise causal 
relationship between the TyG index and CAC remains 
controversial. Second, our study population was rela-
tively small. Third, we did not compare the TyG index 
using the hyperinsulinemic euglycemic clamp test, the 
gold standard method for measuring IR. Fourth, we could 
not record nutritional data. Thus, we could not adjust 
for nutritional habits, which can affect blood triglyceride 
levels. Lastly, the participants in the current study were 
enrolled at one health promotion center, and thus the 
generalizability of the results may be limited.
Conclusions
The TyG index was significantly associated with the 
prevalence of CAC, and this relationship remained sig-
nificant after adjusting for conventional factors. Moreo-
ver, the TyG index was more independently associated 
with the presence of coronary artery atherosclerosis than 
was HOMA-IR in healthy Korean adults. The TyG index 
might be a useful marker of atherosclerosis, reflecting car-
diovascular risk. Further prospective large-scale studies 
are required to clarify the mechanisms of this relationship.
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